Cargando…

中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗现状的调研:从患者的角度

OBJECTIVE: To assess tyrosine kinase inhibitor (TKI) treatment status in patients with chronic myeloid leukemia (CML) in China and analyze the response-associated factors. METHODS: From May to November in 2014, anonymous questionnaires were distributed to adult CML patients who were receiving TKI tr...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365001/
https://www.ncbi.nlm.nih.gov/pubmed/27535854
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.004